Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogGlaxo Settles Lawsuit over Avandia
By Edward Bills
| Drugmaker GlaxoSmithKline Plc has settled a lawsuit filed by the family of a man who allegedly suffered a heart attack after taking the diabetes drug Avandia. The company has also agreed to pay almost half a billion dollars to resolve claims it hid the drug?s health risks. The terms of the settlement were undisclosed. |
Full post as published by Bodily Injury Blog on February 01, 2011 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Copyright Lawsuits: Critical Issues Before Filing Copyright
Federa Rule 11(b) Considerations
Vioxx Lawsuits
Vioxx personal injury suits are a seroius concern for Merck and patietns
Construction Site Accidents
Lawsuits related to accidents
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Avandia
alleging heart attacks, increased fracture risk that may have been caused by Avandia.
US Settles Indian Lawsuit for $3.4 Billion
US Government Settles Indian Lawsuit for $3.4 Billion
Lawry's Restaurants Settles Sex Bias Lawsuit for $1 Million
Lawry's Restaurants Settles Sex Bias Lawsuit for $1Million
Ford Settles SUV Rollover Lawsuit for $21M
Ford Settles SUV Rollover Lawsuit for $21M
Welder Settles for $2M in Personal Injury Lawsuit
Welder Settles for $2M in Personal Injury Lawsuit
Dannon Settles Class Action Lawsuit for $35 Million
Dannon Settles Class Action Lawsuit for $35 Million

10,000 Avandia Lawsuits Settled For $460 Million While FDA Considers Possible Avandia Recall
Avandia Heart Attack: Questions Still Remain
Don't Cry for Avandia Maker Glaxo Just Yet
Glaxo Said to Pay $460 Million to End Avandia Suits
Avandia Decline Not Affecting GlaxoSmithKline
Glaxo Defends Handling of Avandia Heart Risks









